To view a copy of this license, visit About this article Cite this article Sarna, M., Krzykawska-Serda, M., Jakubowska, M
Description Wegovy UK (Semaglutide) A Proven Solution for Weight Management Wegovy (semaglutide) is a prescription injectable medication designed to support weight loss and long-term weight management in adults who are overweight or living with obesity
It is particularly useful for athletes, people in a caloric deficit, vegetarians, and seniors
Research shows that GLP-1 RAs lower the risk of cardiovascular disease, kidney disease, liver disease, and sleep apnea
It is the first medication to meaningfully address both sides of the energy balance equation: | Medication | What It Reduces | What It Burns | Max Weight Loss | |-----------|----------------|---------------|-----------------| | Semaglutide | Appetite (GLP-1) | -- | ~15-17% | | Tirzepatide | Appetite (GIP + GLP-1) | Minimal | ~20-22% | | **Retatrutide** | **Appetite (GIP + GLP-1)** | **Calories (Glucagon)** | **~24%** | That additional glucagon column is why retatrutide achieved more weight loss in less time than either competitor